Radiotherapy after Separation Surgery for Spinal Metastases

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study examines the impact of postoperative radiotherapy on prognosis and survival in patients who have undergone separation surgery for spinal metastases. It describes clinical outcomes and aims to inform future treatment decisions. The study acknowledges common metastatic spine complications and the potential benefits and risks of adding radiotherapy after surgery. Enrollment requires adults who recently had separation surgery, confirmed metastatic disease outside the spine, and a projected survival of at least six months. Geographic site is Shanghai Changzheng Hospital in China, with Wei Xu as the lead sponsor.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. Age over 18 years old, gender not limited;
2. The patient has undergone separation surgery within 3 weeks;
3. The pathological result of the separation surgery site of the patient indicates that the lesion is a metastatic tumor, and the primary lesion is located outside the spine;
4. The expected survival period is ≥ 6 months;
5. The patient has signed the informed consent form.

Exclusion Criteria:

1. Patients with poor general condition and those who are intolerant to radiotherapy, chemotherapy, and targeted therapy;
2. Patients whose treatment segments have not received any other surgical treatment or radiotherapy;
3. Patients who participated in other clinical trials of drugs or medical devices within 3 months before enrollment;
4. Other situations judged by the investigator as making the subject unsuitable for enrollment.

Where it's running

• Shanghai Changzheng Hospital
  Shanghai, Shanghai Municipality, China Recruiting

Study contacts

• Study coordinator: Wei Xu
• Email: xuwei_spine@163.com
• Phone: +8613761278657

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Comparing two surgical approaches for spinal oligometastatic tumors with radiotherapy

  This study is testing whether two different types of surgery combined with radiation can help people with spinal cancer live longer and feel better.

  Recruiting Shanghai Changzheng Hospital · Shanghai, Shanghai Municipality · NCT06120426

• Analysis of outcomes and side effects in patients receiving radiation therapy

  This study looks at the results and side effects of radiation therapy in patients at Winterthur Cantonal Hospital to see how treatment can be improved for future patients.

  Recruiting Kantonsspital Winterthur KSW · Winterthur, Canton of Zurich · NCT05192876

• Primary tumor removal with targeted lymph node removal plus radiation for biliary tract cancer with lymph node spread

  This phase II study tests whether removing the main tumor and select nearby lymph nodes, followed by postoperative radiation, helps patients with biliary tract cancer and lymph node metastases.

  Recruiting Phase 2 Cancer Institute and Hospital, Chinese Academy of Medical Sciences · Beijing, Beijing Municipality · NCT07893392

• Stereotactic body radiation therapy for spinal metastases with epidural compression

  This study tests whether SBRT can safely help adults with spinal metastases that compress the spinal cord see if the treatment works in reducing issues from their cancer.

  Recruiting Tianjin Medical University Cancer Institute and Hospital · Tianjin · NCT07809672

• Tributyrin as a dietary supplement to help prevent radiation-induced rectal injury during rectal cancer chemoradiation

  This study tests whether adding tributyrin to standard chemoradiotherapy helps prevent acute radiation-induced rectal injury in people with locally advanced rectal cancer.

  Recruiting Sixth Affiliated Hospital, Sun Yat-sen University · Guangzhou, Guangdong · NCT07802002

• Postoperative Edge SBRT for Spinal Metastases

  This observational study tests whether high-precision postoperative SBRT with the Edge system can improve local control and neurological outcomes in patients with spinal metastases after surgery.

  Recruiting Tianjin Medical University Cancer Institute and Hospital · Tianjin, Tianjin Municipality · NCT07801274

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.